Value in Healthcare

The World Economic Forum and Boston Consulting Group argue that global healthcare is unsustainable due to costs growing at roughly double the rate of GDP. They propose a 'value-based healthcare' model defined as the ratio of health outcomes that matter to patients relative to the costs required to deliver them. The framework rests on three foundational principles: systematic measurement of outcomes and costs, focusing on distinct population segments, and customizing interventions for those segments. To enable this, the report identifies four key enablers: health informatics, benchmarking/research tools, value-based payments, and reorganized delivery models. It emphasizes that public policy is critical to mandate outcome tracking, balance data privacy with sharing, and establish new payment models to move away from fee-for-service systems.

• Global healthcare sustainability is threatened by costs increasing at approximately twice the rate of gross domestic product (GDP) growth, leading to budget pressures and rationing in some countries.
• A significant amount of global healthcare spending is wasted on unnecessary or unproven treatments; one estimate suggests up to 30% of spending is wasted, with overtreatment costing approximately $750 billion annually in the United States alone.
• Value in healthcare is defined as the ratio of health outcomes delivered to defined patient groups relative to the costs required to achieve them, shifting the focus from volume of procedures to patient-centric results.
• The value-based delivery model is built on three foundational principles: systematically measuring patient-relevant outcomes and costs across the full cycle of care, identifying specific population segments, and developing customized interventions for those segments.
• Four key enablers are necessary to accelerate the transition to value-based care: health informatics for data collection, benchmarking and research tools for clinical improvement, value-based payment models, and new delivery organization structures.
• Current payment systems often create perverse incentives; for example, a US hospital study found that privately insured surgical patients with complications provided a 330% higher profit margin than those without complications.
• Registry-based randomized controlled trials (rRCTs) can significantly reduce research costs—potentially to 10% of traditional trial costs—by integrating patient sampling into routine clinical practice.
• Public policy is essential to the transition, with five priorities: mandating outcome tracking, balancing privacy with data sharing, enabling care pathway partnerships, establishing longitudinal payment models, and making pharmaceutical/medtech companies accountable for value.
• The report outlines a four-phase roadmap for system transformation: starting with internal performance improvement, moving to system-wide learning and benchmarking, then to public transparency and value competition, and finally to a fully optimized, continuously improving value-based system.

APA

World Economic Forum (2017). Value in Healthcare. http://www3.weforum.org/docs/WEF_Insight_Report_Value_Healthcare_Laying_Foundation.pdf

Chicago

World Economic Forum. Value in Healthcare. 2017. http://www3.weforum.org/docs/WEF_Insight_Report_Value_Healthcare_Laying_Foundation.pdf.

Wikipedia

{{cite report |author=World Economic Forum |title=Value in Healthcare |date=April 2017 |url=http://www3.weforum.org/docs/WEF_Insight_Report_Value_Healthcare_Laying_Foundation.pdf |access-date=23 October 2026 |via=Climate Insights Directory}}

BibTeX

@techreport{worldeconomicforum2017value, author = {{World Economic Forum}}, title = {{Value in Healthcare}}, institution = {World Economic Forum}, year = {2017}, month = apr, url = {http://www3.weforum.org/docs/WEF_Insight_Report_Value_Healthcare_Laying_Foundation.pdf}, urldate = {2026-10-23}, note = {Indexed by Climate Insights Directory} }